Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EValuation of prognostIc and Cost reDuction by tElemonitoring iN CIEDs Usual carE: an Updated Analysis Using 2019-2023 Data

NCT07881250 is registered in ClinicalTrials.gov with Implicity as lead sponsor.

NCT NCT07881250
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07881250 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EValuation of prognostIc and Cost reDuction by tElemonitoring iN CIEDs Usual carE: an Updated Analysis Using 2019-2023 Data
Lead sponsor
Implicity
Phase
Observational
Overall status
Active, not recruiting
Start date
October 7, 2026
Completion date
November 15, 2026
Enrollment
100,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac implantable electronic device (cied), cardiovascular diseases (cvd)